Paul E Goss Selected Research

exemestane (Aromasin)

10/2021	Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer.
1/2020	Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α.
1/2020	Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action.
1/2018	Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.
1/2018	Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
7/2017	Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.
12/2016	Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy.
4/2016	Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27.
1/2015	Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial.
5/2014	Quality of life in MAP.3 (Mammary Prevention 3): a randomized, placebo-controlled trial evaluating exemestane for prevention of breast cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul E Goss Research Topics

Disease

96	Breast Neoplasms (Breast Cancer) 02/2022 - 01/2002
37	Neoplasms (Cancer) 07/2022 - 01/2003
8	Osteoporosis 07/2017 - 11/2003
7	Pain (Aches) 07/2022 - 10/2005
4	Arthralgia (Joint Pain) 01/2018 - 11/2003
4	Exanthema (Rash) 04/2015 - 07/2007
4	Bone Resorption 02/2008 - 09/2004
3	T-Cell Leukemia (Leukemia, T Cell) 01/2018 - 03/2012
3	Bone Fractures (Bone Fracture) 07/2016 - 09/2005
3	Uterine Hemorrhage (Uterine Bleeding) 04/2013 - 11/2003
3	Carcinoma (Carcinomatosis) 05/2012 - 10/2003
2	Cardiotoxicity 01/2018 - 07/2007
2	Metabolic Bone Diseases (Osteopenia) 07/2017 - 04/2013
2	Drug-Related Side Effects and Adverse Reactions 01/2017 - 03/2012
2	Musculoskeletal Pain 03/2016 - 03/2012
2	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2011 - 01/2002
2	Neoplasm Metastasis (Metastasis) 12/2008 - 04/2006
2	Arthritis (Polyarthritis) 04/2008 - 11/2003
2	Hot Flashes 02/2008 - 11/2003
2	Endometrial Neoplasms (Endometrial Cancer) 02/2008 - 05/2007
2	Brain Neoplasms (Brain Tumor) 07/2007 - 11/2006
1	Ductal Carcinoma 01/2019
1	Ovarian Epithelial Carcinoma 10/2017
1	Ovarian Neoplasms (Ovarian Cancer) 10/2017
1	Inflammation (Inflammations) 01/2017
1	Secretory breast carcinoma 01/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2016
1	Hypertension (High Blood Pressure) 05/2016
1	Lymphoma (Lymphomas) 03/2016
1	Mental Disorders (Mental Disorder) 01/2016
1	Hyperprolactinemia 01/2016
1	Triple Negative Breast Neoplasms 06/2015

Drug/Important Bio-Agent (IBA)

42	Aromatase InhibitorsIBA 02/2022 - 01/2002
34	Tamoxifen FDA LinkGeneric 07/2016 - 01/2002
31	Hormones (Hormone)IBA 02/2022 - 08/2003
30	Letrozole (Femara)FDA LinkGeneric 02/2022 - 06/2002
22	Estrogens (Estrogen)FDA Link 01/2021 - 01/2002
19	exemestane (Aromasin)FDA Link 10/2021 - 08/2003
17	Anastrozole (Arimidex)FDA LinkGeneric 10/2021 - 08/2003
12	Estrogen ReceptorsIBA 01/2020 - 08/2003
11	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2004
7	Lapatinib (GW572016)FDA Link 03/2016 - 11/2006
6	Aromatase (CYP19)IBA 01/2020 - 01/2002
5	Estradiol (Delestrogen)FDA LinkGeneric 01/2020 - 07/2007
5	Selective Estrogen Receptor Modulators (SERM)IBA 01/2017 - 01/2003
5	Trastuzumab (Herceptin)FDA Link 04/2016 - 01/2013
3	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2019 - 10/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 04/2016 - 05/2005
3	Octreotide (Sandostatin)FDA LinkGeneric 01/2016 - 10/2011
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2012 - 10/2003
2	PlatinumIBA 10/2021 - 06/2015
2	Celecoxib (Celebrex)FDA Link 01/2018 - 04/2008
2	Vitamin D FDA LinkGeneric 01/2018 - 03/2012
2	CytokinesIBA 01/2018 - 03/2012
2	4-azidobenzylcarazolol (pABC)IBA 10/2017 - 01/2015
2	Diphosphonates (Bisphosphonates)IBA 07/2017 - 02/2012
2	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 06/2003
2	human ERBB2 proteinIBA 03/2016 - 04/2015
2	ErbB Receptors (EGF Receptor)IBA 04/2015 - 08/2014
2	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 05/2012 - 01/2007
2	Insulin-Like PeptidesIBA 10/2011 - 01/2008
2	Raloxifene Hydrochloride (Evista)FDA Link 06/2011 - 01/2003
2	Homeodomain Proteins (Proteins, Homeobox)IBA 10/2003 - 06/2003
1	Opioid Analgesics (Opioids)IBA 07/2022
1	Biological ProductsIBA 11/2021
1	Temozolomide (Temodar)FDA LinkGeneric 10/2021
1	Poly Adenosine Diphosphate RiboseIBA 10/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021
1	veliparibIBA 10/2021
1	Fulvestrant (Faslodex)FDA Link 01/2020
1	Estrone FDA Link 01/2020
1	LigandsIBA 01/2020
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	PhosphoproteinsIBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 10/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2017
1	Long Noncoding RNAIBA 12/2016
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2016
1	ProlactinIBA 01/2016
1	Antipsychotic Agents (Antipsychotics)IBA 01/2016
1	Antidepressive Agents (Antidepressants)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Formaldehyde (Formol)FDA Link 01/2016
1	ParaffinIBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2015
1	HLA-DRB1*07 antigenIBA 01/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2015
1	OsteoprotegerinIBA 10/2014

Therapy/Procedure

56	Therapeutics 01/2020 - 01/2002
7	Drug Therapy (Chemotherapy) 10/2017 - 04/2006
4	Palliative Care (Palliative Therapy) 07/2022 - 06/2017
4	Adjuvant Chemotherapy 07/2016 - 11/2003
3	Chemoprevention 01/2020 - 01/2002
2	Terminal Care (Care, Terminal) 06/2017 - 01/2006
1	Cytoreduction Surgical Procedures 10/2017
1	Duration of Therapy 07/2016
1	Adjuvant Radiotherapy 04/2016
1	Contraindications 01/2016